NAPRT1 Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit

Produktübersicht

• Artikelname: NAPRT1 Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit
• Artikelnummer: BSS-BS-19017R-PE-CY5.5
• Hersteller Artikelnummer: bs-19017R-PE-Cy5.5
• Alternativnummer: BSS-BS-19017R-PE-CY5.5-100
• Hersteller: Bioss
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: WB
• Spezies Reaktivität: Mouse
• Konjugation: PE/Cy5.5
• Alternative Synonym: FHA HIT interacting protein, FHA-HIT-interacting protein, FHIP, FHIP, NAPRT1, NAPRTase, Nicotinate phosphoribosyltransferase, Nicotinate phosphoribosyltransferase domain containing 1, Nicotinate phosphoribosyltransferase domain-containing protein 1, Nicotinic acid phosphoribosyltransferase, PNCB_HUMAN, PP3856.

Produktbeschreibung

Nicotinic acid (NA, niacin) is converted by nicotinic acid phosphoribosyltransferase (NAPRT, EC 2.4.2.11) to NA mononucleotide (NaMN), which is then converted to NA adenine dinucleotide (NaAD), and finally to nicotinamide adenine dinucleotide (NAD), which serves as a coenzyme in cellular redox reactions and is an essential component of a variety of processes in cellular metabolism including response to stress (Hara et al., 2007).[supplied by OMIM, Mar 2008]

Produkteigenschaften

• Klonalität: Polyclonal
• Konzentration: 1ug/ul
• NCBI: 93100
• UniProt: Q6XQN6
• Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
• Quelle: KLH conjugated synthetic peptide derived from human NAPRT1
• Target-Kategorie: NAPRT1

Anwendungsbeschreibung

• Application Verdünnung: WB(1:300-5000)